Literature DB >> 11698419

Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade.

A Yamada1, A Chandraker, T M Laufer, A J Gerth, M H Sayegh, H Auchincloss.   

Abstract

To study the role of the direct and indirect pathways in achieving tolerance, we used genetically altered mouse strains in two ways: 1) MHC class II-deficient mice were used as donors of skin and cardiac grafts to eliminate the direct CD4(+) T cell response, and 2) B6 II(-)4(+) mice, which are MHC class II-deficient mice expressing an MHC class II transgene only on thymic epithelium, were used as recipients of normal grafts. These mice cannot mount an indirect response. Eliminating the indirect pathway actually made it more difficult to achieve prolonged allograft survival when we used costimulatory blockade than when both pathways were available. Costimulatory blockade was ineffective even when CD4(+) T cells from normal animals were transferred into recipients that lacked MHC class II molecules. These results suggest that an active CD4(+) response through the indirect pathway is necessary for costimulatory blockade to be effective in prolonging allograft survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698419     DOI: 10.4049/jimmunol.167.10.5522

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism.

Authors:  Kenneth K Wong; Matthew J Carpenter; Lesley L Young; Susan J Walker; Grahame McKenzie; Alyson J Rust; George Ward; Laura Packwood; Karen Wahl; Luc Delriviere; Gerard Hoyne; Paul Gibbs; Brian R Champion; Jonathan R Lamb; Margaret J Dallman
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 2.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 3.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

4.  Costimulation blockade inhibits the indirect pathway of allorecognition in nerve allograft rejection.

Authors:  Wilson Z Ray; Rahul Kasukurthi; Santosh S Kale; Katherine B Santosa; Daniel A Hunter; Philip Johnson; Ying Yan; Thalachallour Mohanakumar; Susan E Mackinnon; Thomas H Tung
Journal:  Muscle Nerve       Date:  2011-01       Impact factor: 3.217

5.  Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation.

Authors:  Alberto Sánchez-Fueyo; Christoph M Domenig; Christophe Mariat; Sophoclis Alexopoulos; Xin X Zheng; Terry B Strom
Journal:  Transpl Int       Date:  2007-03-16       Impact factor: 3.782

Review 6.  Regulatory T-cell therapy in transplantation: moving to the clinic.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

7.  The indirect alloresponse impairs the induction but not maintenance of tolerance to MHC class I-disparate allografts.

Authors:  M J Weiss; D A Guenther; J D Mezrich; H Sahara; C Y Ng; A J Meltzer; J K Sayre; M E Cochrane; A C Pujara; S L Houser; D H Sachs; B R Rosengard; J S Allan; G Benichou; J C Madsen
Journal:  Am J Transplant       Date:  2009-01       Impact factor: 8.086

8.  Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.

Authors:  Thomas Fehr; Fabienne Haspot; Joshua Mollov; Meredith Chittenden; Timothy Hogan; Megan Sykes
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Acute and chronic phagocyte determinants of cardiac allograft vasculopathy.

Authors:  Kristofor Glinton; Matthew DeBerge; Xin-Yi Yeap; Jenny Zhang; Joseph Forbess; Xunrong Luo; Edward B Thorp
Journal:  Semin Immunopathol       Date:  2018-08-23       Impact factor: 9.623

Review 10.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.